KIT and systemic mastocytosis: Several studies have shown that patients with a very low disease burden, who usually fail to meet a full diagnosis of SM and are classified as clonal mast cell activation syndrome (MMAS/cMCAS), display the greatest discrepancies in KIT analysis between BM and PB (49).